Racemic adrenaline and inhalation strategies in acute bronchiolitis
- PMID: 23758233
- DOI: 10.1056/NEJMoa1301839
Racemic adrenaline and inhalation strategies in acute bronchiolitis
Abstract
Background: Acute bronchiolitis in infants frequently results in hospitalization, but there is no established consensus on inhalation therapy--either the type of medication or the frequency of administration--that may be of value. We aimed to assess the effectiveness of inhaled racemic adrenaline as compared with inhaled saline and the strategy for frequency of inhalation (on demand vs. fixed schedule) in infants hospitalized with acute bronchiolitis.
Methods: In this eight-center, randomized, double-blind trial with a 2-by-2 factorial design, we compared inhaled racemic adrenaline with inhaled saline and on-demand inhalation with fixed-schedule inhalation (up to every 2 hours) in infants (<12 months of age) with moderate-to-severe acute bronchiolitis. An overall clinical score of 4 or higher (on a scale of 0 to 10, with higher scores indicating more severe illness) was required for study inclusion. Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was recorded. The primary outcome was the length of the hospital stay, with analyses conducted according to the intention-to-treat principle.
Results: The mean age of the 404 infants included in the study was 4.2 months, and 59.4% were boys. Length of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relative improvement in the clinical score from baseline (preinhalation) were similar in the infants treated with inhaled racemic adrenaline and those treated with inhaled saline (P>0.1 for all comparisons). On-demand inhalation, as compared with fixed-schedule inhalation, was associated with a significantly shorter estimated mean length of stay--47.6 hours (95% confidence interval [CI], 30.6 to 64.6) versus 61.3 hours (95% CI, 45.4 to 77.2; P=0.01) - as well as less use of oxygen supplementation (in 38.3% of infants vs. 48.7%, P=0.04), less use of ventilatory support (in 4.0% vs. 10.8%, P=0.01), and fewer inhalation treatments (12.0 vs. 17.0, P<0.001).
Conclusions: In the treatment of acute bronchiolitis in infants, inhaled racemic adrenaline is not more effective than inhaled saline. However, the strategy of inhalation on demand appears to be superior to that of inhalation on a fixed schedule. (Funded by Medicines for Children; ClinicalTrials.gov number, NCT00817466; EudraCT number, 2009-012667-34.).
Comment in
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1076-7. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024851 No abstract available.
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1075-6. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024852 No abstract available.
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1076. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024853 No abstract available.
-
On-demand, not scheduled, nebulization (epinephrine or saline) improves important clinical outcomes in hospitalized infants with bronchiolitis.J Pediatr. 2013 Nov;163(5):1529-30. doi: 10.1016/j.jpeds.2013.08.055. J Pediatr. 2013. PMID: 24160663 No abstract available.
Similar articles
-
Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: follow-up from the randomised, controlled, double-blind, Bronchiolitis ALL trial.Lancet Respir Med. 2015 Sep;3(9):702-708. doi: 10.1016/S2213-2600(15)00319-7. Epub 2015 Aug 25. Lancet Respir Med. 2015. PMID: 26321593 Clinical Trial.
-
Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076].BMC Pediatr. 2005 May 5;5(1):7. doi: 10.1186/1471-2431-5-7. BMC Pediatr. 2005. PMID: 15876347 Free PMC article. Clinical Trial.
-
Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis.Respir Med. 2000 Jul;94(7):709-14. doi: 10.1053/rmed.2000.0807. Respir Med. 2000. PMID: 10926344
-
Therapeutic strategies for pediatric bronchiolitis.Expert Rev Respir Med. 2019 Jan;13(1):95-103. doi: 10.1080/17476348.2019.1554439. Epub 2018 Dec 5. Expert Rev Respir Med. 2019. PMID: 30488718 Review.
-
[Nebulized hypertonic saline and acute viral bronchiolitis in infants: current aspects].Arch Pediatr. 2012 Jun;19(6):635-41. doi: 10.1016/j.arcped.2012.03.018. Epub 2012 Apr 30. Arch Pediatr. 2012. PMID: 22551894 Review. French.
Cited by
-
Over-investigation and overtreatment in pediatrics: a survey from the European Academy of Paediatrics and Japan Pediatric Society.Front Pediatr. 2024 Feb 22;12:1333239. doi: 10.3389/fped.2024.1333239. eCollection 2024. Front Pediatr. 2024. PMID: 38455393 Free PMC article.
-
Acute Viral Bronchiolitis: A Narrative Review.J Pediatr Intensive Care. 2020 Sep 2;12(2):79-86. doi: 10.1055/s-0040-1715852. eCollection 2023 Jun. J Pediatr Intensive Care. 2020. PMID: 37082471 Free PMC article. Review.
-
Twenty-one-year follow-up revealed guideline-concordant and non-concordant trends in intensive care of bronchiolitis.Eur J Pediatr. 2023 Jun;182(6):2665-2671. doi: 10.1007/s00431-023-04940-2. Epub 2023 Mar 29. Eur J Pediatr. 2023. PMID: 36988679 Free PMC article.
-
Bronchiolitis 2021-2022 epidemic: multicentric analysis of the characteristics and treatment approach in 214 children from different areas in Italy.Eur J Pediatr. 2023 Apr;182(4):1921-1927. doi: 10.1007/s00431-023-04853-0. Epub 2023 Feb 20. Eur J Pediatr. 2023. PMID: 36807514 Free PMC article.
-
Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta-analysis.Health Sci Rep. 2022 Apr 18;5(3):e598. doi: 10.1002/hsr2.598. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35509393 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources